Moderna Inc (MRNA)
38.26
+1.32
(+3.57%)
USD |
NASDAQ |
Nov 21, 16:00
38.21
-0.05
(-0.13%)
After-Hours: 20:00
Moderna Enterprise Value: 7.348B for Nov. 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 7.348B |
| November 19, 2024 | 7.483B |
| November 18, 2024 | 8.337B |
| November 15, 2024 | 7.314B |
| November 14, 2024 | 8.437B |
| November 13, 2024 | 9.349B |
| November 12, 2024 | 9.861B |
| November 11, 2024 | 9.584B |
| November 08, 2024 | 11.15B |
| November 07, 2024 | 12.48B |
| November 06, 2024 | 13.07B |
| November 05, 2024 | 13.64B |
| November 04, 2024 | 13.74B |
| November 01, 2024 | 14.16B |
| October 31, 2024 | 14.05B |
| October 30, 2024 | 14.20B |
| October 29, 2024 | 14.39B |
| October 28, 2024 | 14.23B |
| October 25, 2024 | 13.57B |
| October 24, 2024 | 13.46B |
| October 23, 2024 | 13.69B |
| October 22, 2024 | 13.69B |
| October 21, 2024 | 13.85B |
| October 18, 2024 | 13.96B |
| October 17, 2024 | 14.24B |
| Date | Value |
|---|---|
| October 16, 2024 | 15.26B |
| October 15, 2024 | 15.20B |
| October 14, 2024 | 15.36B |
| October 11, 2024 | 15.57B |
| October 10, 2024 | 15.01B |
| October 09, 2024 | 15.79B |
| October 08, 2024 | 15.61B |
| October 07, 2024 | 15.74B |
| October 04, 2024 | 16.31B |
| October 03, 2024 | 16.64B |
| October 02, 2024 | 17.45B |
| October 01, 2024 | 17.75B |
| September 30, 2024 | 18.86B |
| September 27, 2024 | 16.79B |
| September 26, 2024 | 16.09B |
| September 25, 2024 | 15.97B |
| September 24, 2024 | 16.09B |
| September 23, 2024 | 16.17B |
| September 20, 2024 | 16.76B |
| September 19, 2024 | 17.66B |
| September 18, 2024 | 18.37B |
| September 17, 2024 | 19.18B |
| September 16, 2024 | 18.10B |
| September 13, 2024 | 17.76B |
| September 12, 2024 | 18.30B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
4.881B
Minimum
Jan 07 2020
187.56B
Maximum
Aug 09 2021
46.41B
Average
40.28B
Median
Enterprise Value Benchmarks
| Eli Lilly and Co | 742.91B |
| Merck & Co Inc | 270.08B |
| Pfizer Inc | 198.27B |
| Novavax Inc | 550.83M |
| Vertex Pharmaceuticals Inc | 109.68B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 13.00M |
| Revenue (Quarterly) | 1.855B |
| Total Expenses (Quarterly) | 1.925B |
| EPS Diluted (Quarterly) | 0.03 |
| Gross Profit Margin (Quarterly) | 72.29% |
| Profit Margin (Quarterly) | 0.70% |
| Earnings Yield | -15.21% |
| Normalized Earnings Yield | -14.82 |